City
Palo Alto
41 announced deals involving Palo Alto, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 41 DLA Piper advises Allegion on acquisition of Overly Door Company 3 Nov 2026
DLA Piper advises Arlington Capital Partners and Everest Clinical Research on acquisition of Firma Clinical Research unit 21 Oct 2026
DLA Piper advises POSCO International on US$550 million agreement to acquire Chord’s Marcellus gas assets 19 Oct 2026
DLA Piper advises EliseAI on capital raise at US$4 billion valuation 7 Oct 2026
Mayer Brown represents underwriters on Teva Pharmaceutical’s US$4.9 billion senior notes offering. 22 Sept 2026
DLA Piper advises Quaise Energy on financing for landmark geothermal project 1 Sept 2026
DLA Piper advises Claros on transaction advancing critical technologies for AI computing 1 Sept 2026
Baker McKenzie Advises FlightSafety International on Acquisition of Acron Technologies’ Commercial Training Solutions Business 28 Aug 2026
DLA Piper advises Monaco Enterprises on its US$120 million acquisition by Perimeter Solutions 15 Aug 2026
DLA Piper advises CPE on acquisition of Mammut 6 Aug 2026
DLA Piper advises Elroy Air on US$1 billion business combination and planned Nasdaq listing 30 Jun 2026
DLA Piper advises Andreessen Horowitz on US$30 million investment in Prosper AI 30 Jun 2026
DLA Piper advises GigCapital7 Corp. on closing of business combination with Hadron Energy 8 Jun 2026
DLA Piper advises NextHome on its acquisition by eXp World Holdings 5 Jun 2026
DLA Piper advises Fixated on acquisition of Studio71 5 Jun 2026
DLA Piper advises Silicon Laboratories in US$7.5 billion acquisition by Texas Instruments 10 Feb 2026
DLA Piper advises underwriting syndicate in Public Policy Holding Company’s US IPO 10 Feb 2026
DLA Piper advises Einride AB on proposed business combination with Legato Merger Corp. III 20 Nov 2025
DLA Piper advises Rely Home on H.I.G. Capital investment 20 Nov 2025
Baker McKenzie Advises Lotus Pharmaceutical in Acquisition of Alvogen US 20 Oct 2025
DLA Piper advised Predictive Oncology in US$343.5 million digital asset treasury launch 13 Oct 2025
DLA Piper advises PROS Holdings in its acquisition by Thoma Bravo for $1.4 billion 6 Oct 2025
DLA Piper has advised TOMRA on the acquisition of all US assets from C&C Consolidated Holdings (C&C), LLC 6 Oct 2025
DLA Piper advises Sciforma shareholders as part of the sale of the group to Planview 27 Feb 2025
DLA Piper advises SolarWinds in its acquisition by Turn/River for $4.4 billion 12 Feb 2025
Sidley Advises Ariel Investments in New Women’s Sports-Focused Fund Launch and Initial Investment in NWSL’s New Denver-Based Expansion Team 4 Feb 2025
Baker McKenzie Advises Haier on Completion of the Acquisition of Carrier’s Commercial Refrigeration Business for an EV of USD 775 Million 5 Oct 2024
Sidley Advises Tenyx in Its Acquisition by Salesforce 18 Sept 2024
DLA Piper advises GigCapital7 in US$200 million Initial Public Offering 9 Sept 2024
Cross-Border K&L Gates Team Advises Generative AI Company Leonardo.ai on Sale to Graphic Design Platform Canva 16 Aug 2024
DLA Piper advises Ghost Robotics in its strategic partnership with LIG Nex1 13 Aug 2024
DLA Piper advises Point72 Private Investments in NaturalCycles US$55 million Series C financing round 7 Aug 2024
DLA Piper advises Epps Aviation in business acquisition by SAR Trilogy Management 25 Apr 2023
DLA Piper advises MetaVC Partners in raising US$62 Million Fund 21 Apr 2023
Sidley Represents Atia Vision Inc. in Series E Financing 14 Apr 2023
Baker McKenzie Advises Thomson Reuters in Sale of Majority Interest in Elite, Creating Independent Legal Tech Company 6 Apr 2023
Sidley is Representing United Airlines Ventures in its Investment in Electric Aircraft Startup Heart Aerospace and United Airlines in its Conditional Aircraft Purchase 14 Jul 2021
Sidley Advises KKR on Its Investment in Zwift 16 Sept 2020
Sidley Austin LLP represented Palo Alto Networks in its definitive agreement to acquire The Crypsis Group. 25 Aug 2020
DLA Piper advises WiMi Hologram Cloud on US follow-on public offering 31 Jul 2020
Sidley Represents Hengrui Medicine in its License Agreement with CrystalGenomics 4 May 2020